Compare · ELV vs FTRE
ELV vs FTRE
Side-by-side comparison of Elevance Health Inc. (ELV) and Fortrea Holdings Inc. (FTRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and FTRE operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $86.50B, about 49.8x FTRE ($1.74B).
- FTRE has hit the wire 9 times in the past 4 weeks while ELV has been quiet.
- FTRE has more recent analyst coverage (25 ratings vs 23 for ELV).
- Company
- Elevance Health Inc.
- Fortrea Holdings Inc.
- Price
- -
- -
- Market cap
- $86.50B
- $1.74B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 0
- 9
- Recent ratings
- 23
- 25
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
Latest FTRE
- Chief Operating Officer Morais Mark A. converted options into 11,313 shares and sold $88,985 worth of shares (4,892 units at $18.19), increasing direct ownership by 9% to 77,786 units (SEC Form 4) to cover withholding tax
- New insider Russell Carrie Elizabeth claimed ownership of 1,780 shares (SEC Form 3)
- Chief Executive Officer Thakral Anshul sold $2,026,284 worth of shares (111,857 units at $18.11), decreasing direct ownership by 35% to 204,940 units (SEC Form 4) (for withholding tax)
- Chief Executive Officer Thakral Anshul converted options into 416,666 shares and sold $1,913,111 worth of shares (99,869 units at $19.16) (SEC Form 4) (withholding tax)
- SEC Form 144 filed by Fortrea Holdings Inc.
- SEC Form 4 filed by Interim CFO Smith David Ross
- Director Sanders Machelle sold $174,697 worth of shares (9,700 units at $18.01), decreasing direct ownership by 21% to 36,399 units (SEC Form 4)
- SEC Form 144 filed by Fortrea Holdings Inc.
- SEC Form 144 filed by Fortrea Holdings Inc.
- SEC Form 10-Q filed by Fortrea Holdings Inc.